DuPont de Nemours (NYSE:DD) Price Target Raised to $52.00

DuPont de Nemours (NYSE:DDFree Report) had its price target raised by Mizuho from $46.00 to $52.00 in a research note issued to investors on Tuesday,MarketScreener reports. The firm currently has an outperform rating on the basic materials company’s stock.

DD has been the topic of a number of other reports. KeyCorp upped their price target on shares of DuPont de Nemours from $45.00 to $51.00 and gave the stock an “overweight” rating in a research note on Friday, January 9th. Citigroup boosted their target price on DuPont de Nemours from $47.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday, February 3rd. Wolfe Research raised their price target on DuPont de Nemours from $44.00 to $49.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. Morgan Stanley reduced their price target on DuPont de Nemours from $80.00 to $44.00 in a report on Monday, November 10th. Finally, Argus dropped their price objective on DuPont de Nemours from $86.00 to $52.00 and set a “buy” rating on the stock in a report on Thursday, February 5th. Twelve analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $50.46.

Read Our Latest Report on DD

DuPont de Nemours Stock Performance

DD stock opened at $49.34 on Tuesday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.63 and a current ratio of 2.42. The stock has a market cap of $20.67 billion, a P/E ratio of -26.53, a P/E/G ratio of 3.66 and a beta of 1.10. The firm has a 50 day simple moving average of $43.10 and a 200 day simple moving average of $37.07. DuPont de Nemours has a 52 week low of $22.50 and a 52 week high of $52.66.

DuPont de Nemours (NYSE:DDGet Free Report) last announced its quarterly earnings data on Tuesday, February 10th. The basic materials company reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.03. The firm had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.69 billion. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. The firm’s revenue was up .2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.13 earnings per share. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. Research analysts anticipate that DuPont de Nemours will post 4.38 earnings per share for the current fiscal year.

DuPont de Nemours declared that its Board of Directors has approved a share buyback plan on Thursday, November 6th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the basic materials company to buy up to 12.2% of its shares through open market purchases. Shares buyback plans are often an indication that the company’s board believes its stock is undervalued.

Insider Activity at DuPont de Nemours

In related news, CEO Lori Koch sold 9,011 shares of the business’s stock in a transaction that occurred on Friday, November 28th. The stock was sold at an average price of $39.46, for a total value of $355,574.06. Following the completion of the sale, the chief executive officer directly owned 288,326 shares in the company, valued at approximately $11,377,343.96. The trade was a 3.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Erik T. Hoover sold 6,005 shares of the company’s stock in a transaction that occurred on Friday, November 28th. The stock was sold at an average price of $39.79, for a total value of $238,938.95. Following the sale, the senior vice president directly owned 112,101 shares of the company’s stock, valued at $4,460,498.79. The trade was a 5.08% decrease in their position. The SEC filing for this sale provides additional information. 0.61% of the stock is currently owned by insiders.

Institutional Trading of DuPont de Nemours

Large investors have recently modified their holdings of the company. Advisors Asset Management Inc. grew its stake in DuPont de Nemours by 588.2% in the 4th quarter. Advisors Asset Management Inc. now owns 2,918 shares of the basic materials company’s stock valued at $117,000 after buying an additional 2,494 shares during the last quarter. FineMark National Bank & Trust boosted its holdings in DuPont de Nemours by 21.3% during the fourth quarter. FineMark National Bank & Trust now owns 13,894 shares of the basic materials company’s stock valued at $559,000 after acquiring an additional 2,438 shares during the period. Advocate Investing Services LLC acquired a new stake in shares of DuPont de Nemours in the fourth quarter valued at about $68,000. Federation des caisses Desjardins du Quebec increased its stake in shares of DuPont de Nemours by 36.0% in the fourth quarter. Federation des caisses Desjardins du Quebec now owns 71,105 shares of the basic materials company’s stock worth $2,858,000 after purchasing an additional 18,831 shares during the period. Finally, HRT Financial LP acquired a new position in shares of DuPont de Nemours during the 4th quarter worth about $8,669,000. 73.96% of the stock is owned by institutional investors.

More DuPont de Nemours News

Here are the key news stories impacting DuPont de Nemours this week:

  • Positive Sentiment: Multiple major brokers raised price targets and kept buy/overweight calls (Citigroup, Jefferies, UBS, Wells Fargo, KeyCorp, BMO, Wolfe), boosting upside thesis and supporting the stock’s recent rally. Wolfe Research Raises PT
  • Positive Sentiment: DuPont reported better‑than‑expected Q4 results and provided FY guidance, which pushed the shares to a one‑year high and underpins the upgrades. Q4 Results & Guidance
  • Positive Sentiment: Product recognition: DuPont’s FilmTec™ Fortilife™ XC160UHP reverse‑osmosis element was named an Edison Awards finalist — a modest positive for long‑term growth in water/wastewater markets. Edison Awards Finalist
  • Neutral Sentiment: Morgan Stanley remains on a hold rating for DD, which tempers the otherwise bullish analyst momentum and gives some investors pause. Morgan Stanley Hold
  • Neutral Sentiment: Several retail/investor pieces question whether the recent run makes DD less attractive near‑term (“Is it too late…”), highlighting valuation concerns that can limit further immediate buying. Valuation Commentary
  • Negative Sentiment: Net effect today: profit‑taking and selling into strength after the multi‑broker upgrade wave and the one‑year high—mixed analyst signals (some holds/valuation cautions) left the stock vulnerable to a pullback on higher volume.

DuPont de Nemours Company Profile

(Get Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

See Also

Analyst Recommendations for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.